EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis

Noriko Itaba iD, Ken-Ichiro Abe iD, Yohei Kono iD, Hiroki Shimizu, Hiroyuki Oka, Minoru Morimoto, Daisuke Nanba iD, Goshi Shiota iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Noriko Itaba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, School of Medicine, Faculty of Medicine,…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis, Collagen, Pyrimidinones. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, KanonCure Inc, Advanced Research and Technology of the Ministry of Education, Culture, Sports, Science, and Technology in Japan and KanonCure Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, characterized by excessive accumulation of the extracellular matrix (ECM), is caused by an imbalance between fibrogenesis and fibrolysis. Effective antifibrotic therapy requires the regulation of hepatic stellate cells (HSCs) through the production of collagen and matrix metalloproteinases (MMPs). The TGF-β/Smad and Wnt/β-catenin pathways play central roles in this regulation. In this study, we investigated whether IC-2, a Wnt/β-catenin inhibitor derived from ICG-001, reduces TGF-β/Smad and Wnt/β-catenin signaling in HSCs in vitro. We further examined the anti-fibrotic effects in two fibrosis models: carbon tetrachloride (CCl4)-treated mice and high-fat diet (HFD)-fed ob/ob mice. IC-2 markedly suppressed the TGF-β/Smad and Wnt/β-catenin pathway in HSCs. Furthermore, IC-2 markedly ameliorated liver fibrosis in CCl4-treated mice, accompanied with suppressed HSC activation and enhanced collagenolytic activity. IC-2 also attenuated fibrosis in the livers of HFD-fed mice. Co-immunoprecipitation analysis confirmed that IC-2 disrupts the β-catenin/CREB-binding protein (CBP) complex. IC-2 specifically induced MMP-1 expression in human HSCs, while the JNK inhibitor SP600125 suppressed IC-2-mediated MMP-1 induction at 48 h, but not at 24 h. It is suggested that this delayed effect may be due to a delayed transcriptional response or indirect signaling cascade downstream of JNK activation. These findings demonstrate that IC-2 mitigates liver fibrosis by inhibiting HSC activation and promoting collagenolysis, highlighting its therapeutic potential in cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsLiver CirrhosisCollagenPyrimidinonesAnimalsMiceMaleWnt Signaling Pathwaybeta CateninTransforming Growth Factor betaHumansCarbon TetrachlorideMice, Inbred C57BLSmad ProteinsDiet, High-FatBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

Wnt/β-catenin signal inhibitorhepatic stellate cells activationliver fibrosistherapeutic agent

Substanzen

Collagenbeta CateninTransforming Growth Factor betaCarbon TetrachloridePyrimidinonesSmad ProteinsICG 001Bridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • Division of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Tottori, Japan.
  • KanonCure Inc., Yonago 683-8503, Tottori, Japan.
  • Research Initiative Center, Tottori University, Tottori 680-8550, Tottori, Japan.

ORCID-Profile: Noriko Itaba, Ken-Ichiro Abe, Yohei Kono, Daisuke Nanba, Goshi Shiota

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • KanonCure Inc
  • Advanced Research and Technology of the Ministry of Education, Culture, Sports, Science, and Technology in Japan and KanonCure Inc.

Zitieren

APA

Itaba, N., Abe, K. I., Kono, Y., Shimizu, H., Oka, H., Morimoto, M., Nanba, D., & Shiota, G. (2026). Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219522

Vancouver

Itaba N, Abe KI, Kono Y, Shimizu H, Oka H, Morimoto M, et al. Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219522

BibTeX
@article{Itaba2026,
  author = {Itaba, Noriko and Abe, Ken-Ichiro and Kono, Yohei and Shimizu, Hiroki and Oka, Hiroyuki and Morimoto, Minoru and Nanba, Daisuke and Shiota, Goshi},
  title = {Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219522}
}
Kostenlos starten →